Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 57
Filtrar
1.
Cell Death Differ ; 11(1): 80-9, 2004 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-12970676

RESUMEN

Cell division cycle 25A (Cdc25A) was shown to colocalise both with nuclear and cytoplasmic proteins. Recently, we have demonstrated that overexpressed Cdc25A promoted the survival of rat 423 cells through indirect activation of PKB-protein kinase B. Using a Cdc25A:ER fusion protein, which can be shuttled from the cytoplasm into the nucleus, the present investigation evidences that the antiapoptotic effect of Cdc25A was restricted to its cytoplasmic localisation in rat 423 cells. In contrast, nuclear Cdc25A overexpression caused dephosphorylation and nuclear retention of the proapoptotic transcription factor Forkhead in rhabdomyosarcoma-like 1 (FKHRL1) in human N.1 ovarian carcinoma cells. This resulted in the increased constitutive expression of the FKHRL1 targets Fas ligand and Bim, and promoted apoptosis. Thus, the Cdc25A oncogene, which was found to be frequently overexpressed in certain human cancers, can increase or decrease the susceptibility to apoptosis depending on the cell-type-specific subcellular distribution.


Asunto(s)
Apoptosis/fisiología , Núcleo Celular/metabolismo , Proteínas de Unión al ADN/metabolismo , Proteínas Recombinantes/metabolismo , Factores de Transcripción/metabolismo , Fosfatasas cdc25/metabolismo , Animales , Apoptosis/efectos de los fármacos , Fusión Artificial Génica , Compartimento Celular , Proteínas de Ciclo Celular , Línea Celular Tumoral , Proteína Forkhead Box O1 , Proteína Forkhead Box O3 , Factores de Transcripción Forkhead , Vectores Genéticos , Humanos , Proteínas del Tejido Nervioso , Ratas , Receptores de Estrógenos/genética , Receptores de Estrógenos/metabolismo , Proteínas Recombinantes/genética , Transformación Genética , Factor de Necrosis Tumoral alfa/farmacología , Fosfatasas cdc25/genética
2.
Oncogene ; 20(33): 4542-53, 2001 Jul 27.
Artículo en Inglés | MEDLINE | ID: mdl-11494150

RESUMEN

The phosphatase Cdc25A was shown to be a target of the transcription factor c-Myc. Myc-induced apoptosis appeared dependent on Cdc25A expression and Cdc25A over-expression could substitute for Myc-triggered apoptosis. These findings suggested that an important downstream component of Myc-mediated apoptosis was identified. However and in contrast, we recently reported that during TNFalpha-induced apoptosis, which required c-Myc function, Cdc25A was down-regulated in a human carcinoma cell line. We now provide evidence that Cdc25A rendered the non-transformed rat embryonic cell line 423 refractory to apoptosis, which was induced by serum deprivation and in absence of detectable c-myc levels. The survival promoting activity of cdc25A was abolished upon infection of cells with a full-length cdc25A antisense construct. To identify the signaling proteins mediating the survival function of the phosphatase, cdc25A- and akt- over-expressing pooled clones were exposed to selected chemicals, which inhibit or activate key proteins in signaling pathways. Inhibition of apoptosis by SU4984, NF023 and Rapamycin placed Cdc25A and Akt function downstream of FGF.R, PDGF.R, and compensated G-protein- and PP2A- activity. Interestingly, upon treatment with LY-294002, cdc25A- and akt- over-expressing clones exhibited similar apoptotic patterns as control cells, which indicates that neither Akt- nor Cdc25A-mediated survival functions are dependent on PI.3 kinase activity in rat 423 cells. In cdc25A-overexpressing cells increased levels of serine 473 phosphorylated Akt were found, which co-precipitated with Cdc25A and Raf1. Since activation of proteins requires dephosphorylation of particular residues in addition to site-specific phosphorylation, the anti-apoptotic effect of Cdc25A might derive from its participation in a multimeric protein complex with phosphoAkt and Raf1, two prominent components of survival pathways.


Asunto(s)
Apoptosis/efectos de los fármacos , Proteínas de Arabidopsis , Medio de Cultivo Libre de Suero/farmacología , Fosfatasas cdc25/fisiología , Animales , Línea Celular/efectos de los fármacos , Cromonas/farmacología , Citocinas/farmacología , Depresión Química , Doxiciclina/farmacología , Embrión de Mamíferos/citología , Factor 2 de Crecimiento de Fibroblastos/farmacología , Regulación de la Expresión Génica , Genes myc , Sustancias de Crecimiento/farmacología , Péptidos y Proteínas de Señalización Intercelular , Sustancias Macromoleculares , Morfolinas/farmacología , Péptidos/farmacología , Fosforilación , Piperazinas/farmacología , Proteínas de Plantas/fisiología , Factor de Crecimiento Derivado de Plaquetas/farmacología , Canales de Potasio/fisiología , Procesamiento Proteico-Postraduccional , Proteínas Proto-Oncogénicas c-myc/fisiología , Proteínas Proto-Oncogénicas c-raf/fisiología , Ratas , Proteínas Recombinantes de Fusión/fisiología , Sirolimus/farmacología , Suramina/análogos & derivados , Suramina/farmacología , Transfección
3.
Onkologie ; 24(1): 22-6, 2001 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11441276

RESUMEN

More than 80% of human malignancies express telomerase activity, while normal somatic tissues in general lack it. During each normal cell division, there is a constant loss of DNA sequences at chromosomal ends, which is due to the 'end-replication problem' of conventional DNA polymerase. Critical shortening of telomeres induces cell cycle arrest and eventually cell death. Telomerase, a ribonucleoprotein complex with a RNA (TR) and a catalytic subunit (TERT) as core components, is able to add reitineratedly telomeric repeat sequences to the very ends of chromosomes. It was suggested that activation of telomerase in tumor cells has a major impact on their continuous growth. Indeed, transfection of TERT constructs into various normal human cell types led to telomere elongation or stabilization and, most importantly, cellular immortalization. Conversely, inhibition of telomerase in tumor cell lines induced growth arrest, at least in first experimental settings. Such initial success implies that drug-mediated abrogation of telomerase action might be an ideal adjuvant treatment for cancer patients. There are, however, legitimate concerns about the generalization of such an approach.


Asunto(s)
División Celular/efectos de los fármacos , Inhibidores Enzimáticos/uso terapéutico , Neoplasias/tratamiento farmacológico , Telomerasa/antagonistas & inhibidores , División Celular/fisiología , Supervivencia Celular/efectos de los fármacos , Supervivencia Celular/fisiología , Inhibidores Enzimáticos/efectos adversos , Humanos , Neoplasias/enzimología , Telomerasa/fisiología , Células Tumorales Cultivadas/efectos de los fármacos , Células Tumorales Cultivadas/enzimología
4.
J Cell Biochem Suppl ; Suppl 36: 1-11, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11455565

RESUMEN

The Harvey-ras gene encodes small guanine nucleotide binding proteins, mutant forms of which are associated with a number of human malignancies. Based on studies with truncated forms of the protein it is known that correct post-translational processing of Ras is essential for cytoplasmic membrane localization and function. Surprisingly, immunofluorescence analysis provided evidence that in addition to its cytosolic localization, activated H-Ras(Val 12) was also localized in the nuclei of transformed cells both in vitro and in vivo. Immunoblot analysis of nuclear fractions was consistent with results found by immunohistochemistry. Moreover, inhibition of protein farnesylation prevented the nuclear targeting of activated H-Ras(Val 12) and NFkappaB. Alterations in subcellular distribution pattern and phosphorylation of the cell cycle inhibitor p27, which is involved in Ras driven tumor growth, coincided with nuclear localization of H-Ras(Val 12). Proteins are often not functional until they are transported to their final destination. Indeed, Ras was found to complex with NTF2 a factor involved in nuclear protein import and export. Therefore it is suggested that NTF2 is the actual carrier for oncogenic Ras. In view of these observations the question arises whether the nuclear localization of H-Ras(Val 12) in tumors is important in oncogenic activation or whether it is a response to apoptosis. J. Cell. Biochem. Suppl. 36: 1-11, 2001.


Asunto(s)
Proteínas Nucleares/metabolismo , Proteínas de Transporte Nucleocitoplasmático , Proteínas Oncogénicas/metabolismo , Fracciones Subcelulares/metabolismo , Proteínas Supresoras de Tumor , Proteínas ras/metabolismo , Transferasas Alquil y Aril/antagonistas & inhibidores , Animales , Western Blotting , Proteínas Portadoras/metabolismo , Proteínas de Ciclo Celular/metabolismo , Línea Celular , Inhibidor p27 de las Quinasas Dependientes de la Ciclina , Dietilnitrosamina , Inhibidores Enzimáticos/farmacología , Técnica del Anticuerpo Fluorescente , Hígado/metabolismo , Hígado/ultraestructura , Neoplasias Hepáticas Experimentales/inducido químicamente , Neoplasias Hepáticas Experimentales/metabolismo , Ratones , Ratones Endogámicos C3H , Microscopía Electrónica , FN-kappa B/metabolismo , Pruebas de Precipitina , Procesamiento Proteico-Postraduccional , Ratas
7.
Mutat Res ; 462(1): 31-47, 2000 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-10648922

RESUMEN

Normal human somatic cells have a finite life span in vivo as well as in vitro and retire into senescence after a predictable time. Cellular senescence is triggered by the activation of two interdependent mechanisms. One induces irreversible cell cycle exit involving activation of two tumorsuppressor genes, p53 and pRb, and the proper time point is indicated by a critical shortening of chromosomal ends due to the end-replication problem of DNA synthesis. The development of a malignant cancer cell is only possible when both mechanisms are circumvented. The majority of human cancers and tumor cell lines produce telomerase, a ribonucleoprotein with two components required for core enzyme activity: telomerase RNA (TR) and a telomerase reverse transcriptase protein (TERT). Telomerase adds hexameric DNA repeats (TTAGGG) to telomeric ends and thus compensates the progressive loss of telomeric sequences inherent to DNA replication. While TR of telomerase is present in almost all human cells, human TERT (hTERT) was found rate limiting for telomerase activity. Ectopic expression of hTERT in otherwise mortal human cells induced efficient elongation of telomeres and permanent cell growth. While hTERT-mediated immortalization seems to have no effect on growth potential and cell cycle check points, it bestows an increased susceptibility to experimental transformation. One oncogene that might activate TERT in the natural context is c-myc. Myc genes are frequently deregulated in human tumors and myc overexpression may cause telomerase reactivation and telomere stabilization which, in turn, would allow permanent proliferation. Is this a general strategy of incipient cancer cells to escape senescence? Several recent observations indicate that other scenarios may be conceived as well.


Asunto(s)
Senescencia Celular/genética , Genes myc/genética , Telomerasa/genética , Telomerasa/metabolismo , Telómero/genética , Animales , Dominio Catalítico , División Celular/genética , Transformación Celular Neoplásica/genética , Proteínas de Unión al ADN , Humanos , Ratones , Ratones Noqueados , ARN/metabolismo , Telómero/metabolismo
8.
Int J Cancer ; 83(4): 526-31, 1999 Nov 12.
Artículo en Inglés | MEDLINE | ID: mdl-10508490

RESUMEN

Murine SCC-VII squamous carcinoma cells have the capacity to penetrate reconstituted basement membranes (Matrigel) in vitro. The invasion of Matrigel layers by SCC-VII cells was significantly reduced by E-64, a specific inhibitor of lysosomal cysteine proteinases. The cathepsin-B-selective E-64 derivative, CA-074, inhibited penetration of Matrigel by SCC-VII cells to the same extent, indicating a major role for this particular lysosomal enzyme in extracellular-matrix degradation during squamous-carcinoma-cell invasion. SCC-VII cells were stably transfected with a cDNA encoding human procathepsin B, in an attempt to modulate the invasive properties of the cell line. The transfected cells expressed the heterologous gene, secreted increased amounts of procathepsin B and displayed enhanced invasive potential. In vivo, the activity of cathepsin B is strictly regulated by endogenous inhibitors. SCC-VII cells were therefore also stably transfected with a cDNA encoding human cystatin C, the most potent cysteine-proteinase inhibitor in mammalian tissues. The expression of this transgene resulted in the production of active recombinant cystatin C and a pronounced reduction in Matrigel invasion. These studies demonstrate that the invasive properties of squamous-cell carcinomas can be changed by modulation of the balance between cathepsin B and its endogenous inhibitors, and provide further evidence for the involvement of this lysosomal cysteine proteinase in tumour invasion and metastasis.


Asunto(s)
Carcinoma de Células Escamosas/metabolismo , Catepsina B/biosíntesis , Cistatinas/biosíntesis , Inhibidores de Cisteína Proteinasa/biosíntesis , Precursores Enzimáticos/biosíntesis , Animales , Northern Blotting , Carcinoma de Células Escamosas/enzimología , Carcinoma de Células Escamosas/patología , Catepsina B/antagonistas & inhibidores , Catepsina B/genética , Quimiotaxis , Colágeno/metabolismo , Medios de Cultivo Condicionados/metabolismo , Cistatina C , Cistatinas/genética , Inhibidores de Cisteína Proteinasa/genética , Combinación de Medicamentos , Precursores Enzimáticos/antagonistas & inhibidores , Precursores Enzimáticos/genética , Matriz Extracelular/metabolismo , Expresión Génica , Humanos , Laminina/metabolismo , Ratones , Invasividad Neoplásica/genética , Proteoglicanos/metabolismo , Proteínas Recombinantes/biosíntesis , Proteínas Recombinantes/genética , Transfección , Células Tumorales Cultivadas
9.
Oncogene ; 17(4): 511-20, 1998 Jul 30.
Artículo en Inglés | MEDLINE | ID: mdl-9696045

RESUMEN

The proto-oncoprotein c-Myc and the multifunctional transcriptional regulator YY1 have been shown previously to interact directly in a manner that excludes Max from the complex (Shrivastava et al., 1993). As binding to Max is necessary for all known c-Myc activities we have analysed the influence of YY1 on c-Myc function. We demonstrate that YY1 is a potent inhibitor of c-Myc transforming activity. The region in YY1 required for inhibition corresponds to a functional DNA-binding domain and is distinct from the domains necessary for direct binding to c-Myc. Furthermore the transactivation domain of YY1 was not necessary suggesting that gene regulation by YY1, for example through DNA bending or displacement of regulators from DNA, could be the cause for the negative regulation of c-Myc. This model of indirect regulation of c-Myc by YY1 was supported by the finding that although YY1 did not bind to the c-Myc transactivation domain (TAD) in vitro it was able to inhibit transactivation by Gal4-MycTAD fusion proteins in transient transfections. As for the inhibition of transformation, an intact DNA-binding domain of YY1 was necessary and sufficient for this effect. In addition YY1 did not alter c-Myc/Max DNA binding, further supporting an indirect mode of action. Our findings point to a role of YY1 as a negative regulator of cell growth with a possible involvement in tumor suppression.


Asunto(s)
Transformación Celular Neoplásica , Proteínas de Unión al ADN/metabolismo , Proteínas Proto-Oncogénicas c-myc/genética , Factores de Transcripción/metabolismo , Activación Transcripcional , Alanina , Animales , Factores de Transcripción Básicos con Cremalleras de Leucinas y Motivos Hélice-Asa-Hélice , Factores de Transcripción con Cremalleras de Leucina de Carácter Básico , Sitios de Unión , Células COS , Células Cultivadas , ADN/metabolismo , Proteínas de Unión al ADN/genética , Factores de Unión al ADN Específico de las Células Eritroides , Genes ras , Glicina , Proteínas Proto-Oncogénicas c-myc/biosíntesis , Ratas , Factor de Transcripción YY1
10.
Mol Biol Rep ; 24(4): 221-30, 1997 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-9403864

RESUMEN

We report on the expression of mouse RNase MRP RNA in human embryonic kidney 293 cells upon DNA transfection. Stable cell lines were selected by cotransfection with a neor gene. Transcription of wild-type and deletion mutants of MRP RNA and ribonucleoprotein formation were assessed by RNase protection and immunoprecipitation experiments. Mouse MRP RNA as expressed in 293 cells readily associates with human proteins to form a chimeric Th ribonucleoprotein. 5' truncated MRP RNAs, however, failed to associate with Th antigen(s) and deletion of the 3' sequences of MRP RNA greatly reduced the expression in stable as well as in transient transfectants.


Asunto(s)
Endorribonucleasas/genética , Endorribonucleasas/metabolismo , Animales , Células Cultivadas , Humanos , Riñón/citología , Riñón/embriología , Ratones , Mutación , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Ribonucleoproteínas/metabolismo , Transcripción Genética , Transfección
11.
Biochem Mol Biol Int ; 42(5): 1015-22, 1997 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-9285070

RESUMEN

Incubation of bovine aortic as well as human umbilical vein endothelial cells with either oxidized or native low-density-lipoprotein in the presence of trace amounts of copper induced morphological changes of the cells and chromatin fragmentation characteristic for programmed cell death. Shrinkage of cells was evident after 6 to 8 hours of incubation and clearly preceded release of lactate dehydrogenase as a marker of cell permeability. Condensation of nuclear chromatin and internucleosomal cleavage was demonstrated by Hoechst staining and gel electrophoresis, respectively. Thus, by inducing active death of endothelial cells oxidized low-density-lipoprotein might negatively influence tissue homeostasis of the endothelium and thereby promote the development of atherosclerotic plaques.


Asunto(s)
Apoptosis/efectos de los fármacos , Endotelio Vascular/patología , Lipoproteínas LDL/farmacología , Animales , Bovinos , Células Cultivadas , Endotelio Vascular/metabolismo , Humanos , L-Lactato Deshidrogenasa/metabolismo
13.
Res Virol ; 147(5): 301-11, 1996.
Artículo en Inglés | MEDLINE | ID: mdl-8880999

RESUMEN

Infection by human papillomavirus type 16 (HPV16) has been associated with cervical dysplasia and carcinoma. To detect a possible cellular immune response against HPV16, we investigated the induction of T cells specific for antigens encoded by the virus. Two CD4+ T-cell lines with a specific proliferative response were isolated from the spleens of rats vaccinated using vaccinia virus vectors expressing E6 or E7 and challenged with syngeneic HPV-transformed cells. Two CD8+ T-cell lines with a specific cytotoxic activity were obtained from mice immunized using a syngeneic squamous cell tumour cell line transfected with the full-length HPV16 DNA. These results demonstrate that both CD8-mediated cytotoxic responses and CD4-mediated delayed-type hypersensitivity responses are involved in immunologic reactions to HPV antigens.


Asunto(s)
Antígenos Virales/inmunología , Linfocitos T CD4-Positivos/inmunología , Proteínas Oncogénicas Virales/inmunología , Papillomaviridae/inmunología , Proteínas Represoras , Linfocitos T Citotóxicos/inmunología , Animales , Antígenos Virales/genética , División Celular , Línea Celular , Línea Celular Transformada , Cricetinae , Femenino , Humanos , Ratones , Ratones Endogámicos BALB C , Proteínas Oncogénicas Virales/genética , Papillomaviridae/genética , Proteínas E7 de Papillomavirus , Ratas , Ratas Endogámicas F344 , Linfocitos T Citotóxicos/citología , Células Tumorales Cultivadas
14.
Biochem Biophys Res Commun ; 224(1): 96-102, 1996 Jul 05.
Artículo en Inglés | MEDLINE | ID: mdl-8694840

RESUMEN

We have recently reported that mutant but not wild-type (wt) p53 protein was ADP-ribosylated in primary rat cells overexpressing the temperature-sensitive murine p53val135 gene. To examine whether the lack of susceptibility to modification is a specific feature of p53val135 adopting wt conformation or rather a general property of this tumor suppressor protein, we have studied ADP-ribosylation of wt p53 of different origin in vitro using semi-purified poly(ADP-ribose) transferase (pADPRT). In vitro pADPRT modified human and mouse wt p53 and p53val135. Under limiting substrate concentration, the molar mass of ADP-ribosylated p53 was only slightly altered. Chase experiments with high NAD concentration resulted in the formation of poly(ADP-ribosyl)ated p53 protein shifted to 64 kD. However, preincubation of wt p53 proteins with a p53 consensus sequence resulting in complex formation abolished the modification of wt p53. This indicates that in the cellular environment the specific DNA binding of wt p53 prevents its covalent modification by poly(ADP-ribose).


Asunto(s)
Poli(ADP-Ribosa) Polimerasas/metabolismo , Proteína p53 Supresora de Tumor/metabolismo , Adenosina Difosfato Ribosa/metabolismo , Animales , Células Cultivadas , Secuencia de Consenso , Embrión de Mamíferos , Embrión no Mamífero , Humanos , Ratones , NAD/metabolismo , Ratas , Ratas Endogámicas F344 , Proteínas Recombinantes/biosíntesis , Proteínas Recombinantes/metabolismo , Spodoptera , Especificidad por Sustrato , Transfección , Proteína p53 Supresora de Tumor/biosíntesis
15.
J Cell Biochem ; 62(1): 90-101, 1996 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-8836878

RESUMEN

Poly(ADP-ribosyl)ation of mutant and wild-type p53 was studied in transformed and nontransformed rat cell lines constitutively expressing the temperature-sensitive p53135val. It was found that in both cell types at 37.5 degrees C, where overexpressed p53 exhibits mutant conformation and cytoplasmic localization, a considerable part of the protein was poly(ADP-ribosyl)ated. Using densitometric scanning, the molecular mass of the modified protein was estimated as 64 kD. Immunofluorescence studies with affinity purified anti-poly(ADP-ribose) transferase (pADPRT) antibodies revealed that, contrary to predictions, the active enzyme was located in the cytoplasm, while in nuclei chromatin was depleted of pADPRT. A distinct intracellular localization and action of pADPRT was found in the cell lines cultivated at 32.5 degrees C, where p53 adopts wild-type form. Despite nuclear coexistence of both proteins no significant modification of p53 was found. Since the strikingly shared compartmentalization of p53 and pADPRT was indicative of possible complex formation between the two proteins, reciprocal immunoprecipitation and immunoblotting were performed with anti-p53 and anti-pADPRT antibodies. A poly(ADP-ribosyl)ated protein of 116 kD constantly precipitated at stringent conditions was identified as the automodified enzyme. It is concluded that mutant cytoplasmic p53 is tightly complexed to pADPRT and becomes modified. At 32.5 degrees C binding to DNA of p53 or its temperature-dependent conformational alteration might prevent an analogous modification of the tumor suppressor protein.


Asunto(s)
Adenosina Difosfato Ribosa/metabolismo , Proteína p53 Supresora de Tumor/metabolismo , Animales , División Celular/genética , Línea Celular , Transformación Celular Neoplásica/genética , Calor , Mutación , Fenotipo , Ratas , Ratas Endogámicas F344 , Proteína p53 Supresora de Tumor/genética
16.
Oncogene ; 11(3): 587-96, 1995 Aug 03.
Artículo en Inglés | MEDLINE | ID: mdl-7630643

RESUMEN

c-Myc is an essential component of the regulatory mechanisms controlling cell growth. Max is the obligatory partner of c-Myc for all its biological functions analysed to date. Recently two Max interacting proteins, Mad and Mxi1, have been identified. It has been suggested that these two proteins modulate c-Myc function, in the simplest model by competing with c-Myc for the interaction with Max. We have analysed different aspects of Mad function in comparison to Max. Native Mad/Max heterodimers bound specifically to a c-Myc/Max consensus DNA binding site. Furthermore Mad inhibited efficiently c-Myc, mutant p53, adenovirus E1a, or human papilloma virus type 16 transformation of rat embryo cells in cooperation with activated Ha-Ras. Myc transformed clones showed an increased cell cycle time and a reduced immortalization frequency after cotransfection with either mad or max. In contrast to Mad, Max did not inhibit E1a/Ha-Ras cotransformation but repressed c-Myc/Ha-Ras transformation efficiently. Mad delta N, an N-terminal deletion mutant of Mad, was as efficient in repressing c-Myc/Ha-Ras cotransformation as full length Mad but showed little inhibitory activity when assayed on E1a/Ha-Ras. Unlike wt Mad, Mad delta N had little effect on cell growth. Our data suggest that Mad affects cell growth at least in part by a c-Myc independent mechanism.


Asunto(s)
Transformación Celular Neoplásica , Proteínas de Unión al ADN/fisiología , Proteínas Oncogénicas Virales/fisiología , Proteínas Proto-Oncogénicas c-myc/fisiología , Proteínas Proto-Oncogénicas p21(ras)/fisiología , Proteínas Represoras , Factores de Transcripción , Animales , Secuencia de Bases , Factores de Transcripción Básicos con Cremalleras de Leucinas y Motivos Hélice-Asa-Hélice , Factores de Transcripción con Cremalleras de Leucina de Carácter Básico , Ciclo Celular , Línea Celular , Chlorocebus aethiops , Expresión Génica , Genes myc , Genes ras , Sustancias Macromoleculares , Datos de Secuencia Molecular , Mutagénesis Sitio-Dirigida , Oligodesoxirribonucleótidos/química , ARN Mensajero/genética , Relación Estructura-Actividad , Transfección
17.
Virology ; 181(1): 62-9, 1991 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-1847269

RESUMEN

Papillomaviruses are etiological agents of epithelial proliferative disease. In man, neoplastic transformation of the uterine cervix has been linked to infection with specific subtypes of human papillomavirus, particularly types 16 and 18. We previously reported that live vaccinia virus recombinants expressing early transforming proteins of other tumor viruses can immunize against challenge with cognate tumor cells and we have extended this approach to HPV16. Neoplastic transformation by papillomaviruses involves expression of early open reading frames (ORFs) E5, E6, and E7, and we report the construction of vaccinia recombinants separately expressing ORFs E5-E7 of HPV16. Primary rat cell lines cotransformed with HPV16 and an activated ras oncogene were established in order to evaluate the potential of the recombinants to elicit antitumor immunity. We report that inoculation of rats with vaccinia recombinants expressing E6 or E7 retarded or prevented tumor development in a proportion of animals challenged by subcutaneous seeding of tumor cells whereas the recombinant expressing E5 was inactive.


Asunto(s)
Transformación Celular Neoplásica , Genes Virales , Papillomaviridae/inmunología , Infecciones Tumorales por Virus/inmunología , Virus Vaccinia/inmunología , Vacunas Virales/administración & dosificación , Animales , Secuencia de Bases , Genes ras , Datos de Secuencia Molecular , Sondas de Oligonucleótidos , Sistemas de Lectura Abierta , Papillomaviridae/genética , Ratas , Ratas Endogámicas F344 , Recombinación Genética , Transfección , Virus Vaccinia/genética , Proteínas Virales/genética , Proteínas Virales/inmunología
18.
Oncogene ; 5(11): 1645-51, 1990 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-2176280

RESUMEN

Drug-resistant clones selected from FR3T3 rat cells after transfer of neo-BPV1 (Bovine Papillomavirus Type 1) DNA constructs became phenotypically transformed (focal transformation, growth in suspension and tumor formation) soon after selection (approximately 5 generations in culture). A frameshift mutation in ORF E5 abolished transformation, but did not prevent the autonomous maintenance of the DNA construct. A more complex situation was observed when the E2 transactivating function was abrogated. A minority of the E2(-)-neor clones became phenotypically transformed shortly after drug selection, but the majority maintained normal growth properties for 30 to 50 generations. The rate of viral transcription was uniformly high in cells which exhibited transformed growth properties early after selection (the E2- minority class and all the wild type transformants) and low in phenotypically normal cells (the majority of the E2- lines). The same low transcriptional activity and delayed expression of transformed growth properties had been observed after transfection of a similar construct carrying a wild type viral early region (69-T fragment), but lacking the late region. The elevated rate of viral transcription, which correlates with the immediate expression of transformation, appears therefore to require at least two distinct elements, the E2 transactivator function and sequences in the late region of the viral genome. In their absence, high transcription rates and transformation could be established only in a minority of the transfected clones, by an unknown, E2-independent mechanism. Evidence was obtained for a third transformation route which, in the absence of either E2 or the late region, led to the focal occurrence of transformed derivatives after 30 to 50 generations of normal growth, but was not associated with an overall increase in viral expression.


Asunto(s)
Papillomavirus Bovino 1/genética , Transformación Celular Neoplásica , Transformación Celular Viral , Regulación de la Expresión Génica , Genes Virales , Transcripción Genética , Animales , Línea Celular , ADN Viral/genética , Fibroblastos , Mutación , Fenotipo , Plásmidos , Ratas , Transfección
19.
Virology ; 177(2): 427-36, 1990 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-1695409

RESUMEN

Transfer of human papillomavirus type 11 (HPV11) DNA and a neo(r) marker into primary rat embryo cells (REC) led to colony formation in G418-selective medium. About 20% of HPV11 clones were eventually established in culture but displayed low growth rates. Cotransfection of HPV11 DNA and an activated ras oncogene led to formation of both drug-resistant flat colonies and phenotypically transformed clones which grew efficiently when expanded in culture. A number of transformants reverted to a flat, "normal" morphology shortly after isolation. Nontransformed clones expressed only HPV11 genes, while those maintaining a transformed phenotype transcribed both ras and HPV11 genes efficiently and were highly tumorigenic. Expression of HPV11 thus seems, necessary for induction of colony formation, but efficient long-term growth seems to require at least the transient presence of ras.


Asunto(s)
Transformación Celular Viral , ADN Viral/genética , Genes ras , Papillomaviridae/genética , Transfección , Animales , Antibacterianos/farmacología , Northern Blotting , Southern Blotting , División Celular , Células Clonales , ADN Viral/aislamiento & purificación , Resistencia a Medicamentos/genética , Embrión de Mamíferos , Femenino , Gentamicinas/farmacología , Humanos , Cinética , Neoplasias Experimentales/patología , Plásmidos , ARN/aislamiento & purificación , Ratas , Ratas Endogámicas F344
20.
Proc Natl Acad Sci U S A ; 86(9): 3266-70, 1989 May.
Artículo en Inglés | MEDLINE | ID: mdl-2541438

RESUMEN

Transfer of neor and bovine papillomavirus type 1 (BPV1) DNA into rat embryo fibroblasts led to colony formation in G418-containing medium, with no detectable background in controls with neor DNA alone. More than 50% of the drug-resistant clones could be further propagated in culture. The genetic functions of BPV1 involved in colony formation and in long-term immortalization were investigated by both translation termination mutations in the full-length genome, which inactivate individual open reading frames, and constructs in which these open reading frames were separately expressed under control of long terminal repeat promoter enhancers. Expression of either open reading frame E2 or E5 was sufficient for formation of a drug-resistant colony, but long-term growth in culture required that of E6. No significant cooperative effect was observed upon cotransfection of BPV1 and ras oncogene DNAs. Expression of the early region of the human papillomavirus type 16 also led to immortalization of rat embryo fibroblast cells in the same assay, and, unlike what was previously reported in baby rat kidney cells, it required neither activation by a heterologous promoter, nor a cooperating ras oncogene.


Asunto(s)
Papillomavirus Bovino 1/genética , Transformación Celular Neoplásica , ADN Viral/genética , Fibroblastos/metabolismo , Genes Virales , Papillomaviridae/genética , Transfección , Animales , Células Cultivadas , Farmacorresistencia Microbiana/genética , Embrión de Mamíferos , Mutación , Oncogenes , Plásmidos , Regiones Promotoras Genéticas , Ratas , Secuencias Repetitivas de Ácidos Nucleicos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA